Table 1.
Clinical Characteristics of PE Patients and Univariate Analysis According to Clinical Outcomes.
| Variable | Whole Group (N = 436) | In-Hospital Mortality (N = 38) | 90-day Mortality (N = 57) | Overall Mortality (N = 102) | Readmission (N = 146) |
|---|---|---|---|---|---|
| Age (years), (median IQR) | 64.0 (54.0-74.0) | 66.0 (57.0-73.0) | 67.0 (59.0-73.0) | 68.0 (61.0-78.0)‡ | 64.5 (55.0-73.0) |
| Sex: Male, n (%) Female, n (%) | 215 (49.3%) 221 (50.7%) | 14 (36.8%)* 24 (63.2%)* | 21 (36.8%)* 36 (63.2%)* | 42 (41.2%) 60 (59.8%) | 60 (41.1%)* 86 (58.9%)* |
| Weight (kg) (median IQR) | 87.0 (70.35-105.97) | 73.95 (66.10-88.30)† | 70.80 (59.60-88.00)‡ | 73.15 (62.10-88.70)‡ | 87.25 (70.20-104.30) |
| BMI (kg/m2) (median IQR) | 29.73 (24.93-35.68) | 26.73 (21.46-30.97)* | 25.45 (21.41-32.28)‡ | 26.04 (22.53-31.47)‡ | 29.74 (25.21-35.67) |
| PE severity ACC/AHA | |||||
| Low risk, n (%) | 153 (35.1%) | 7 (18.4%)* | 12 (21.1%)* | 24 (23.5%)† | 45 (30.8%) |
| Submassive, n (%) | 248 (56.9%) | 24 (63.2%) | 37 (64.9%) | 66 (64.7%) | 92 (63.0%) |
| Massive, n (%) | 35 (8%) | 7 (18.4%)* | 8 (14.0%) | 12 (11.8%) | 9 (6.2%) |
| PE severity ESC | |||||
| Low risk, n (%) | 52 (11.9%) | 0 (0.0%) | 1 (1.8%) | 3 (2.9%) | 17 (11.6%) |
| Intermediate-Low, n (%) | 221 (50.7%) | 17 (44.7%) | 26 (45.6%) | 50 (49.0%) | 74 (50.7%) |
| Intermediate-High, n (%) | 128 (29.4%) | 14 (36.8%) | 22 (38.6%) | 37 (36.3%) | 46 (31.5%) |
| High risk, n (%) | 35 (8.0%) | 7 (18.4%)* | 8 (14.0%) | 12 (11.8%) | 9 (6.2%) |
| Additional risk factors | |||||
| Recent surgery, n (%) | 82 (18.8%) | 7 (18.4%) | 9 (15.8%) | 16 (15.7%) | 27 (18.5%) |
| Immobilization, n (%) | 123 (28.2%) | 13 (34.2%) | 18 (31.6%) | 32 (31.4%) | 34 (23.3%) |
| Estrogen therapy / Oral contraceptive, n (%) | 8 (1.8%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Pregnancy Postpartum, n (%) | 3 (0.7%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (0.7%) |
| Hypercoagulable state, n (%) | 158 (36.2%) | 25 (65.8%)‡ | 36 (63.2%)‡ | 55 (53.9%)‡ | 51 (34.9%) |
| Provoked VTE, n (%) | 249 (57.1%) | 30 (78.9%)† | 45 (78.9%)‡ | 79 (77.5%)‡ | 79 (54.1%) |
Comparisons between patients with versus without clinical outcome. *P < .05; †P < .01; ‡P < .001.